> top > docs > PMC:7205724 > spans > 289-467 > annotations

PMC:7205724 / 289-467 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
5 42-50 Disease denotes COVID-19 MESH:C000657245
7 125-133 Disease denotes COVID-19 MESH:C000657245
10 138-141 Gene denotes IL6 Gene:3569

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 42-50 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 125-133 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T5 105-120 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 105-120 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T2 42-50 Species denotes COVID-19 NCBItxid:2697049
T3 125-133 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T7 52-134 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
5 42-50 Disease denotes COVID-19 MESH:C000657245
7 125-133 Disease denotes COVID-19 MESH:C000657245
10 138-141 Gene denotes IL6 Gene:3569

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 138-141 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T42 11-16 MD denotes might
T43 17-27 VB denotes accelerate
T44 28-36 NN denotes recovery
T45 37-41 IN denotes from
T46 42-50 NN denotes COVID-19
T47 52-53 PDT denotes •
T48 55-57 DT denotes No
T49 58-68 VBN denotes controlled
T50 69-77 JJ denotes clinical
T51 78-84 NNS denotes trials
T52 85-90 VBP denotes exist
T53 91-93 IN denotes on
T54 94-97 DT denotes the
T55 98-101 NN denotes use
T56 102-104 IN denotes of
T57 105-120 NNS denotes corticosteroids
T58 121-124 IN denotes for
T59 125-133 NN denotes COVID-19
T60 135-136 LS denotes •
T61 138-141 NN denotes IL6
T62 142-152 VBZ denotes correlates
T63 153-157 IN denotes with
T64 158-166 NN denotes severity
T65 166-167 -COMMA- denotes ,
R38 T43 T42 arg2Of accelerate,might
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R59 T64 T65 arg1Of severity,","

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 42-50 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 125-133 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T7 52-134 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.